Comments
Loading...

Vistagen Therapeutics

VTGNNASDAQ
Logo brought to you by Benzinga Data
$2.93
0.062.09%
At close: -
$3.01
0.082.72%
After Hours: 5:15 PM EDT

Vistagen Therapeutics (NASDAQ:VTGN) Stock, Earnings Estimates, EPS, And Revenue

Vistagen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 13
EPS
$-0.460
Quarterly Revenue
$234.00K
Annual Revenue
(as of Dec 31)
$698.00K

Analyze the earnings history of Vistagen Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Vistagen Therapeutics (VTGN) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32025-02-13$-0.46$-0.5211.5 %
Q22024-11-07$-0.42$-0.39-7.69 %
Q12024-08-13$-0.35$-0.4012.5 %
Q42024-06-11$-0.25$-0.3732.4 %

Vistagen Therapeutics (VTGN) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32025-02-13$234.00K$179.25K30.5 %
Q22024-11-07$183.00K$220.00K-16.8 %
Q12024-08-13$84.00K$300.00K-72.0 %
Q42024-06-11$197.30K$410.00K-51.9 %

FAQ

Q

When is Vistagen Therapeutics (NASDAQ:VTGN) reporting earnings?

A

Vistagen Therapeutics (VTGN) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 13, 2025 for Q3.

Q

What were the latest earnings per share (EPS) for Vistagen Therapeutics (NASDAQ:VTGN)?

A

Vistagen Therapeutics (VTGN) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 13, 2025 for Q3 and the Actual EPS was $-0.46, which beat the estimate of $-0.52.

Q

What were Vistagen Therapeutics’s (NASDAQ:VTGN) revenues?

A

Vistagen Therapeutics (VTGN) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 13, 2025 for Q3 and the Actual Revenue was $234K, which beat the estimate of $179.3K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch